What is LAMA2-CMD?

Laminin Alpha-2 Congenital Muscular Dystrophy (LAMA2-CMD), also known as Merosin-Deficient Congenital Dystrophy Type 1A (MDC1A), is a genetic disorder that causes the weakening and wasting of the muscles used for moving and breathing.

Affecting 1 to 4 people in every 100,000, LAMA2-CMD is the most common form of the congenital muscular dystrophies.

What is MDC1A?
The Website

Our Mission

Our mission is to further advance awareness and research for LAMA2-CMD internationally and to directly support patients and families by providing relevant information and resources.

This website brings together the international LAMA2-CMD community and centralises all information, education, community news and research and industry updates directly relating to the fight against LAMA2-CMD.

By including the patients and families, and by collaborating with the clinicians, researchers and members of the biotech industry involved with LAMA2-CMD around the world, we aim to accelerate the road to therapy in a truly united and collective global effort.

Find more on our objectives and who we are here.

Donate now

Support the research for a cure and donate now!

Knowledge

Stay up to date

2019 conference

Watch the 2019 MDC1A conference

  • This field is for validation purposes and should be left unchanged.

Ask the expert

Do you have a question for one of the experts or researchers with whom we are in contact? About an investigation, a treatment method or other information that you are looking for? Submit your question and we will get you a personal answer as soon as possible. We will also publish the answer on this website. 

We use cookies to make sure our website works properly and in order to improve the performance of our website. By using this website, or by clicking the “accept” button, you give your consent for the use of cookies.